Bausch Health Companies is a global pharmaceutical company focused on developing, manufacturing, and marketing a range of pharmaceutical, ophthalmological, and consumer healthcare products.
An analysis of the bond market reveals insights into specific instruments, such as the now-matured XS1206091651 bond, originally issued by Bausch Health Companies, a Canada-based multinational specialty pharmaceutical company primarily focused on eye health, gastroenterology, and dermatology. This USD-denominated obligation, which traded at 100% of its face value prior to its maturity on May 14, 2023, carried an annual interest rate of 4.5%, with interest payments distributed semi-annually. The total issuance size for this instrument was $1,500,000,000, with a minimum purchase increment of $100,000. Notably, this specific bond has successfully reached its maturity and has since been fully redeemed.
|
Français
Italiano
Canada
XS1206091651 ( in USD )
